Biological monitoring of carcinogens: Current status and perspectives

Archives of Toxicology

Volumn 86, Issue 4, 2012, Pages 535-541

  Pavanello, Sofia ^a   Lotti, Marcello ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Biomonitoring; Carcinogens; Effects; Exposures; Personalized medicine; Susceptibility

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN;

BIOLOGICAL MONITORING; CANCER CELL; CANCER RISK; CARCINOGENESIS; CELL TYPE; EXPOSURE; GENETIC ASSOCIATION; GENETIC DISORDER; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; METABOLOMICS; MICROENVIRONMENT; NEOPLASM; NUTRITION; ONCOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; CARCINOGENICITY TESTS; CARCINOGENS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; GENOMICS; HUMANS; METABOLOMICS; NEOPLASMS; RISK ASSESSMENT;

EID: 84862889578     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-011-0793-z     Document Type: Review

References (85)

1. Abbas T, Dutta A (2009) p21 in cancer: intricate networks and multiple. activities. Nat Rev Cancer 9:400-414.
2. Airoldi L, Orsi F, Magagnotti C, Coda R, Randone D, Casetta G et al. (2002) Determinants of 4-aminobiphenyl-DNA adducts in bladder. cancer biopsies. Carcinogenesis 23:861-866.
3. Airoldi L, Vineis P, Colombi A, Olgiati L, Dell'Osta C, Fanelli R et al. (2005) 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-. related disease in never smokers and former smokers in the. European Prospective Investigation into Cancer and Nutrition. prospective Study. Cancer Epidemiol Biomarkers Prev 14:2118-. 2124.
4. Aldrich MC, Selvin S, Hansen HM, Barcellos LF, Wrensch MR, Sison. JD et al (2009) CYP1A1/2 haplotypes and lung cancer and assessment. of confounding by population stratiWcation. Cancer Res. 69:2340-2348.
5. Ally MS, Al-Ghnaniem R, Pufulete M (2009) The relationship. between gene-speciWc DNA methylation in leukocytes and normal. colorectal mucosa in subjects with and without colorectal. tumors. Cancer Epidemiol Biomarkers Prev 18:922-928.
6. Angerer J, Ewers U, Wilhelm M (2007) Human biomonitoring: state of. the art. Int J Hyg Environ Health 210:201-228.
7. Artandi SE, DePinho RA (2010) Telomeres and telomerase in cancer. Carcinogenesis 31:9-18.
8. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D et al. (2007) Changes in DNA methylation patterns in subjects exposed. to low-dose benzene. Cancer Res 67:876-880.
9. Bolognesi C, Creus A, Ostrosky-Wegman P, Marcos R (2011) Micronuclei. and pesticide exposure. Mutagenesis 26:19-26.
10. Bonassi S, Neri M, Lando C, Ceppi M, Lin YP, Chang WP et al (2003). HUMN collaborative group. EVect of smoking habit on the frequency. of micronuclei in human lymphocytes: results from the. Human MicroNucleus project. Mutat Res 543:155-166.
11. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N et al. (2007) An increased micronucleus frequency in peripheral blood. lymphocytes predicts the risk of cancer in humans. Carcinogenesis. 28:625-631.
12. Bonassi S, Norppa H, Ceppi M, Strömberg U, Vermeulen R, Znaor A. et al (2008) Chromosomal aberration frequency in lymphocytes. predicts the risk of cancer: results from a pooled cohort study of. 22,358 subjects in 11 countries. Carcinogenesis 29:1178-1183.
13. Brandt HC, Watson WP (2003) Monitoring human occupational and. environmental exposures to polycyclic aromatic compounds. Ann. Occup Hyg 47:349-378.
14. Butler MA, Guengerich FP, Kadlubar FF (1989a) Metabolic oxidation of. the carcinogens 4-aminobiphenyl and 4, 4-methylene-bis(2-chloroaniline). by human hepatic microsomes and by puriWed rat hepatic. cytochrome P-450 monooxygenases. Cancer Res 49:25-31.
15. Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF (1989b) Human. cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase,. is primarily responsible for the hepatic 3-demethylation of. caVeine and N-oxidation of carcinogenic arylamines. Proc Natl. Acad Sci USA 86:7696-7700.
16. Calado RT, Young NS (2009) Telomere diseases. N Engl J Med. 361:2353-2365.
17. Carreón T, LeMasters GK, Ruder AM, Schulte PA (2006) The genetic. and environmental factors involved in benzidine metabolism and. bladder carcinogenesis in exposed workers. Front Biosci. 11:2889-2902.
18. Carton T, Tan XD, Hartemann P, Joyeux M (2007) Use of genotypic. selection to detect P53 codon 273 CGTCTT transversion:. application to an occupationally exposed population. Int J Hyg. Environ Health 210:69-77.
19. Cedar H, Bergman Y (2009) Linking DNA methylation and histone. modiWcation: patterns and paradigms. Nat Rev Genet 10:295-304.
20. Cogliano VJ (2010) Identifying carcinogenic agents in the workplace. and environment. Lancet Oncol 11:602.
21. De Vivo I, Prescott J, Wong JY, Kraft P, Hankinson SE, Hunter DJ. (2009) A prospective study of relative telomere length and postmenopausal. breast cancer risk. Cancer Epidemiol Biomarkers. Prev 18:1152-1156.
22. de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF,. van den Brandt PA et al (2009) MGMT and MLH1 promoter. methylation versus APC, KRAS and BRAF gene mutations in. colorectal cancer: indications for distinct pathways and sequence. of events. Ann Oncol 20:1216-1222.
23. Deitz AC, Rothman N, Rebbeck TR, Hayes RB, Chow WH, Zheng W. et al (2004) Impact of misclassiWcation in genotype-exposure. interaction studies: example of N-acetyltransferase 2 (NAT2),. smoking, and bladder cancer. Cancer Epidemiol Biomarkers Prev. 13:1543-1546.
24. DeMarini DM (2004) Genotoxicity of tobacco smoke and tobacco. smoke condensate: a review. Mutat Res 567:447-474.
25. Doll MA, Zang Y, Moeller T, Hein DW (2010) Codominant expression. of N-acetylation and O-acetylation activities catalyzed by. N-acetyltransferase 2 in human hepatocytes. J Pharmacol Exp. Ther 334:540-544.
26. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U (2008). Genetic susceptibility to cancer: the role of polymorphisms in. candidate genes. JAMA 299:2423-2436.
27. Fenech M (2002) Chromosomal biomarkers of genomic instability relevant. to cancer. Drug Discov Today 7:1128-1137.
28. Fenech M, Holland N, Zeiger E, Chang WP, Burgaz S, Thomas P et al. (2011a) The HUMN and HUMNxL international collaboration. projects on human micronucleus assays in lymphocytes and buccal. cells-past, present and future. Mutagenesis 26:239-245.
29. Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW,. Parry J et al (2011b) Molecular mechanisms of micronucleus,. nucleoplasmic bridge and nuclear bud formation in mammalian. and human cells. Mutagenesis 26:125-132.
30. Frood A (2010) Technology: a Xavour of the future. Nature 468:S21-. S22.
31. García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M,. Hein DW et al (2005) NAT2 slow acetylation, GSTM1 null genotype,. and risk of bladder cancer: results from the Spanish Bladder. Cancer Study and meta-analyses. Lancet 366:649-659.
32. Godschalk RW, Van Schooten FJ, Bartsch H (2003) A critical evaluation. of DNA adducts as biological markers for human exposure to. polycyclic aromatic compounds. J Biochem Mol Biol 36:1-11.
33. Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA. repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev 11:1513-1530.
34. Guimaraes DP, Hainaut P (2002) TP53: a key gene in human cancer. Biochimie 84:83-93.
35. GyorVy E, Anna L, Gyori Z, Segesdi J, Minárovits J, Soltész I et al. (2004) DNA adducts in tumour, normal peripheral lung and bronchus,. and peripheral blood lymphocytes from smoking and nonsmoking. lung cancer patients: correlations between tissues and. detection by 32P-postlabelling and immunoassay. Carcinogenesis. 25:1201-1209.
36. GyorVy E, Anna L, Kovács K, Rudnai P, Schoket B (2008) Correlation. between biomarkers of human exposure to genotoxins with focus. on carcinogen-DNA adducts. Mutagenesis 23:1-18.
37. Hamburg MA, Collins FS (2010) The path to personalized medicine. N Engl J Med 363:301-304.
38. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674.
39. Hanash SM, Baik CS, Kallioniemi O (2011) Emerging molecular biomarkers-. blood-based strategies to detect and monitor cancer. Nat. Rev Clin Oncol 8:142-150.
40. Hayes RB, Bi W, Rothman N, Broly F, Caporaso N, Feng P et al (1993). N-acetylation phenotype and genotype and risk of bladder cancer in. benzidine-exposed workers. Carcinogenesis 14:675-678.
41. Hein DW, Millner LM, Leggett CS, Doll MA (2010) Relationship. between N-acetyltransferase 2 single-nucleotide polymorphisms. and phenotype. Carcinogenesis 31:326-327.
42. HuV J (2011) Primary prevention of cancer. Science 332:916-917.
43. Iarmarcovai G, Botta A, Orsière T (2006) Number of centromeric signals. in micronuclei and mechanisms of aneuploidy. Toxicol Lett. 166:1-10.
44. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. (2001) Replication validity of genetic association studies. Nat. Genet 29:306-309.
45. Iorio MV, Croce CM (2009) MicroRNAs in cancer: small molecules. with a huge impact. J Clin Oncol 27:5848-5856.
46. Jakowlew SB (2006) Transforming growth factor- in cancer and. metastasis. Cancer Metastasis Rev 25:435-457.
47. Kadlubar FF, Miller JA, Miller EC (1977) Hepatic microsomal N-glucuronidation. and nucleic acid binding of N-hydroxy arylamines in. relation to urinary bladder carcinogenesis. Cancer Res 37:805-814.
48. Lahiri DK (2011) An integrated approach to genome studies. Science. 331:147.
49. Lee KM, Kang D, Clapper ML, Ingelman-Sundberg M, Ono-Kihara. M, Kiyohara C et al (2008) CYP1A1, GSTM1, and GSTT1 polymorphisms,. smoking, and lung cancer risk in a pooled analysis. among Asian populations. Cancer Epidemiol Biomarkers Prev. 17:1120-1126.
50. Lee IM, Lin J, Castonguay AJ, Barton NS, Buring JE, Zee RY (2010). Mean leukocyte telomere length and risk of incident colorectal. carcinoma in women: a prospective, nested case-control study. Clin Chem Lab Med 48:259-262.
51. Lilla C, Verla-Tebit E, Risch A, Jäger B, HoVmeister M, Brenner H. et al (2006) EVect of NAT1 and NAT2 genetic polymorphisms on. colorectal cancer risk associated with exposure to tobacco smoke. and meat consumption. Cancer Epidemiol Biomarkers Prev. 15:99-107.
52. Mahata J, Chaki M, Ghosh P, Das LK, Baidya K, Ray K et al (2004). Chromosomal aberrations in arsenic-exposed human populations:. a review with special reference to a comprehensive study in West. Bengal, India. Cytogenet Genome Res 104:359-364.
53. Manolio TA, Collins FS, Cox NJ, Goldstein DB, HindorV LA, Hunter. DJ et al (2009) Finding the missing heritability of complex diseases. Nature 461:747-753.
54. McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I (2007) Telomere. length, cigarette smoking, and bladder cancer risk in men. and women. Cancer Epidemiol Biomarkers Prev 16:815-819.
55. Nöthlings U, Yamamoto JF, Wilkens LR, Murphy SP, Park SY,. Henderson BE et al (2009) Meat and heterocyclic amine intake,. smoking, NAT1 and NAT2 polymorphisms, and colorectal. cancer risk in the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev 18:2098-2106.
56. Olesen PT, Olsen A, Frandsen H, Frederiksen K, Overvad K,. Tjønneland A (2008) Acrylamide exposure and incidence of. breast cancer among postmenopausal women in the Danish Diet,. Cancer and Health Study. Int J Cancer 122:2094-2100.
57. Patel CJ, Bhattacharya J, Butte AJ (2010) An Environment-Wide. Association Study (EWAS) on type 2 diabetes mellitus. PLoS. One 5:e10746.
58. Pavanello S, Bollati V, Pesatori AC, Kapka L, Bolognesi C, Bertazzi. PA et al (2009) Global and gene-speciWc promoter methylation. changes are related to anti-B[a]PDE-DNA adduct levels and. inXuence micronuclei levels in polycyclic aromatic hydrocarbonexposed. individuals. Int J Cancer 125:1692-1697.
59. Pavanello S, Pesatori AC, Dioni L, Hoxha M, Bollati V, Siwinska E. et al (2010) Shorter telomere length in peripheral blood lymphocytes. of workers exposed to polycyclic aromatic hydrocarbons. Carcinogenesis 31:216-221.
60. Pavanello S, Hoxha M, Dioni L, Bertazzi PA, Snenghi R, Nalesso A. et al (2011) Shortened telomeres in individuals with abuse in. alcohol consumption. Int J Cancer 129:983-992.
61. Peluso M, Neri M, Margarino G, Mereu C, Munnia A, Ceppi M et al. (2004) Comparison of DNA adduct levels in nasal mucosa, lymphocytes. and bronchial mucosa of cigarette smokers and interaction. with metabolic gene polymorphisms. Carcinogenesis 25:. 2459-2465.
62. Petronis A (2010) Epigenetics as a unifying principle in the aetiology. of complex traits and diseases. Nature 465:721-727.
63. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A,. Jones D et al (2010) A small-cell lung cancer genome with complex. signatures of tobacco exposure. Nature 463:184-190.
64. Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN et al. (2010) Telomere length in prospective and retrospective cancer. case-control studies. Cancer Res 70:3170-3176.
65. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE et al. (1994) A follow-up study of urinary markers of aXatoxin exposure. and liver cancer risk in Shanghai, People's Republic of. China. Cancer Epidemiol Biomarkers Prev 3:3-10.
66. Rappaport SM, Smith MT (2010) Epidemiology. Environment and. disease risks. Science 330:460-461.
67. Ricceri F, Godschalk RW, Peluso M, Phillips DH, Agudo A, Georgiadis P. et al (2010) Bulky DNA adducts in white blood cells: a pooled. analysis of 3,600 subjects. Cancer Epidemiol Biomarkers Prev. 19:3174-3181.
68. Rodriguez-Antona C, Gomez A, Karlgren M, Sim SC, Ingelman-Sundberg. M (2010) Molecular genetics and epigenetics of the cytochrome. P450 gene family and its relevance for cancer risk and treatment. Hum Genet 127:1-17.
69. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X,. Figueroa JD et al (2010) A multi-stage genome-wide association. study of bladder cancer identiWes multiple susceptibility loci. Nat. Genet 42:978-984.
70. Smolders R, Bartonova A, Boogaard PJ, Dusinska M, Koppen G,. Merlo F et al (2010) The use of biomarkers for risk assessment:. reporting from the INTARESE/ENVIRISK Workshop in Prague. Int J Hyg Environ Health 213:395-400.
71. Sram RJ, Beskid O, Binkova B, Chvatalova I, Lnenickova Z, Milcova. A et al (2007) Chromosomal aberrations in environmentally. exposed population in relation to metabolic and DNA repair. genes polymorphisms. Mutat Res 620:22-33.
72. Stratton MR (2011) Exploring the genomes of cancer cells: progress. and promise. Science 331:1553-1558.
73. Szyf M (2011) The implications of DNA methylation for toxicology:. toward toxicomethylomics, the toxicology of DNA methylation. Toxicol Sci 120:235-255.
74. Thomas D (2010) Gene-environment-wide association studies: emerging. approaches. Nat Rev Genet 11:259-272.
75. Vähäkangas K (2003) TP53 mutations in workers exposed to occupational. carcinogens. Hum Mutat 21:240-251.
76. Veglia F, Loft S, Matullo G, Peluso M, Munnia A, Perera F et al (2008). Genair-EPIC Investigators. DNA adducts and cancer risk in prospective. studies: a pooled analysis and a meta-analysis. Carcinogenesis. 29:932-936.
77. Vineis P, Perera F (2007) Molecular epidemiology and biomarkers in. etiologic cancer research: the new in light of the old. Cancer Epidemiol. Biomarkers Prev 16:1954-1965.
78. Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK. et al (2001) Current smoking, occupation, N-acetyltransferase-2. and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 10:1249-1252.
79. Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, Rosa F. et al (2009) A Weld synopsis on low-penetrance variants in DNA. repair genes and cancer susceptibility. J Natl Cancer Inst 101:24-36.
80. Weisel CP (2010) Benzene exposure: an overview of monitoring methods. and their Wndings. Chem Biol Interact 184:58-66.
81. Wiencke JK, Kelsey KT, Varkonyi A, Semey K, Wain JC, Mark E et al. (1995) Correlation of DNA adducts in blood mononuclear cells. with tobacco carcinogen-induced damage in human lung. Cancer. Res 55:4910-4914.
82. Wiencke JK, Thurston SW, Kelsey KT, Varkonyi A, Wain JC, Mark. EJ et al (1999) Early age at smoking initiation and tobacco carcinogen. DNA damage in the lung. J Natl Cancer Inst 91:614-619.
83. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstätter A. et al (2010) Telomere length and risk of incident cancer and cancer. mortality. JAMA 304:69-75.
84. Yuan JM, Koh WP, Murphy SE, Fan Y, Wang R, Carmella SG et al. (2009) Urinary levels of tobacco-speciWc nitrosamine metabolites. in relation to lung cancer development in two prospective cohorts. of cigarette smokers. Cancer Res 69:2990-2995.
85. Zee RY, Castonguay AJ, Barton NS, Buring JE (2009) Mean telomere. length and risk of incident colorectal carcinoma: a prospective,. nested case-control approach. Cancer Epidemiol Biomarkers Prev. 18:2280-2282